Company Overview and News

 
How can the business leaders of tomorrow, save the planet today

2018-10-04 bworldonline
Sustainability has become a bit of a buzzword in recent months, used in everything from fashion to tourism. According to the Brundtland Report, sustainability is “development that meets the needs of the present without compromising the ability of future.” But what does that mean in business practice? And how can today’s current generation of pioneers use it to build the future of business?
FPHPC EGDCY EDC 532219 FPHP ENERGYDEV FPH

 
Bourse surprises with ‘dizzying rally’

2018-09-21 bworldonline
THE PHILIPPINE STOCK EXCHANGE index (PSEi) exited bear territory on Friday amid what one analyst described as “a dizzying rally”, but its strong recovery was not enough to prevent its third straight week-on-week drop.
FPHPC MPCIY BDOUY AYAAY UVRBY AEV FPHP DD SECB MRAIF BDOUF BDO ABTZY MPI MPCFF SYBJF URC MRC ALI FPH UVRBF AYAAF

 
Tax court drops utilities firm’s bid for review

2018-09-16 bworldonline
THE COURT of Tax Appeals (CTA) En Banc has dismissed the petition for review filed by First Philippine Utilities Corp. for lack of jurisdiction over the case.
FPHPC FPHP FPH

 
ArteFino 2018: Watch out for intricate beadwork of Davao’s Bagobo Tagabawa tribe

2018-08-21 lifestyle.inquirer.net
Clockwise from left: Marimel Francisco, Zarah Juan, Bae Arlyn Salazar, Maritess Pineda, Cedie Vargas, Mita Rufino, Suzy Quiros with the Bagobo Tagabawa community
FPHPC FPHP FPH

 
Energy unit boosts Lopez Holdings’ second-quarter earnings

2018-08-14 bworldonline
LOPEZ Holdings Corp. reported a net income of P1.03 billion in the second quarter, higher by 43% compared with year ago’s P721-million profit attributable to the equity holders of the parent firm, with the stable showing of its energy unit boosting the quarterly results.
FPHPC FSGCF FGENG FGENF MER FGEN FSGCY LPZ FPHP FPH

 
Lopez Holdings Q2 earnings surge by 43%

2018-08-14 bworldonline
Lopez Holdings Corp. reported a net income of P1.03 billion in the second quarter, higher by 43% compared with year ago’s P721-million profit attributable to the equity holders of the parent firm, with the stable showing of its energy unit boosting the quarterly results.
FPHPC FSGCF FGENG FGENF FGEN FSGCY LPZ FPHP FPH

 
The Arangkada Philippines Fora 2018

2018-07-04 business.inquirer.net
The Joint Foreign Chambers of Commerce of the Philippines (JFC) will host two major events this year: the Seventh Anniversary Arangkada Philippines Forum entitled “Better Infrastructure for a Strong Economy” and a special Creative Industries Forum entitled “Creative Industries: The Next Sunrise Industry.”
FPHPC MWC MPCFF MPCIY MWP MPI FPHP MWIDE FPH

3
Lopez-led FPH sets P22-billion capex for 2018

2018-05-28 bworldonline - 1
LOPEZ-LED First Philippine Holdings Corp. (FPH) is setting aside a budget of P22 billion for 2018, with its property development segment cornering the bulk of the capital expenditures, the company treasurer said on Monday.
FSGCF FGENG FGENF FGEN FSGCY FPH

1
Lopez nets P1.14B

2018-05-14 business.inquirer.net
Conglomerate Lopez Holdings booked a 10-percent year-on-year increase in first quarter net profit to P1.14 billion, backed by a double-digit growth in earnings from its power generation and broadcasting businesses.
FPHPC LPZ FPHP FPH

1
How ‘Tata Oskie’ changed a millennial’s mind

2018-05-12 lifestyle.inquirer.net
Towards midday, Marianna found herself walking beside Tata Oskie and Nana Connie. She was most surprised when Tata Oskie stopped and asked her, ‘Do you know the name of this tree?’
FPHPC FPHP FPH

2
Lopez Holdings 2017 profit down 36%

2018-04-17 business.inquirer.net
Conglomerate Lopez Holdings posted a net profit of P4.22 billion last year, down by 36 percent in the absence of one-off gains and election season-related surge in media advertising revenue that jacked up its bottom line in 2016.
FPHPC FSGCF FGENG FGENF FGEN FSGCY LPZ FPHP FPH

2
Lopez Holdings income declines 36% in 2017

2018-04-17 bworldonline
THE absence of one-time gains that inflated profits in 2016 dragged earnings Lopez Holdings, Inc. last year.
FPHPC FSGCF FGENG FGENF FGEN FSGCY LPZ FPHP FPH

2
Lopez Holdings 2017 profits down on lack of one-time gains

2018-04-17 bworldonline
The absence of one-time gains that inflated profits in 2016 dragged earnings of Lopez Holdings, Inc. last year.
FPHPC FSGCF FGENG FGENF FGEN FSGCY LPZ FPHP FPH

2
Lopez nets P4.2B

2018-04-17 business.inquirer.net
Conglomerate Lopez Holdings chalked up a net profit of P4.22 billion last year, down by 36 percent in the absence of one-off gains and election season-related surge in media advertising revenues that jacked up earnings in 2016.
FPHPC FSGCF FGENG FGENF FGEN FSGCY FPHP FPH

8
First Philippine Holding 2017 recurring profit up 15%

2018-04-06 bworldonline
FIRST Philippine Holdings Corp. (FPH) reported on Friday a 15% increase in 2017 net profit on a recurring basis to P6.8 billion, which excludes a one-off item in connection with debt prepayments by unit First Gen Corp.
FPHPC EGDCY FSGCY 532219 FPHP ENERGYDEV FSGCF FGENG FGENF FGEN EDC FPH

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PSE:FPH / First Philippine Holdings Corporation on message board site Silicon Investor.

Fountain Pharmaceuticals (FPHI) Fountain Pharmaceuticals (FPHI) Fountain Pharmaceuticals (FPHI)